
    
      Participants will be randomly assigned to either receive 300 mg of BUP-XL or 450 mg of BUP-XL
      with an aim to quit smoking. They will take the medication for 8 weeks while simultaneously
      receiving counseling to set a quit date and stay motivated to quit. Medication will be
      administered for 4 weeks before and 4 weeks after designated quit-date. Post-treatment
      follow-up appointment will be scheduled for 8, 16, and 26 weeks post treatment so assess
      commitment to quitting and overall success of the study.
    
  